The inactivation of intrinsic antibiotic resistance determinants widens the mutant selection window for quinolones in Stenotrophomonas maltophilia

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 12, 2012, Pages 6397-6399

  García León, Guillermo ^a   Sánchez, María B ^a   Martínez, José L ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLONE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONCENTRATION (PARAMETERS); DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; MUTANT; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA; WILD TYPE;

DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; OFLOXACIN; QUINOLONES; STENOTROPHOMONAS MALTOPHILIA;

EID: 84869210385     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01558-12     Document Type: Article

References (23)

1. Alonso A, Martinez JL. 2000. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 44:3079-3086.
2. Alonso A, Martinez JL. 2001. Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 45:1879-1881.
3. Alonso A, Martinez JL. 1997. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41:1140-1142.
4. Baquero F, Negri MC. 1997. Selective compartments for resistant microorganisms in antibiotic gradients. Bioessays 19:731-736.
5. Baquero F, Negri MC, Morosini MI, Blazquez J. 1998. Antibiotic-selective environments. Clin. Infect. Dis. 27(Suppl 1):S5-S11.
6. Crossman LC, et al. 2008. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 9:R74.
7. Drlica K. 2003. The mutant selection window and antimicrobial resistance. J. Antimicrob. Chemother. 52:11-17.
8. Drlica K, Zhao X. 2007. Mutant selection window hypothesis updated. Clin. Infect. Dis. 44:681- 688.
9. Fajardo A, et al. 2008. The neglected intrinsic resistome of bacterial pathogens. PLoS One 3:e1619. doi:10.1371/journal.pone.0001619.
10. Li X, Mariano N, Rahal JJ, Urban CM, Drlica K. 2004. Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin. Antimicrob. Agents Chemother. 48:4460-4462.
11. Liang B, et al. 2011. Mutant prevention concentration-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus. Antimicrob. Agents Chemother. 55:2409-2412.
12. Lira F, et al. 2012. Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain. J. Bacteriol. 194:3563-3564.
13. Looney WJ, Narita M, Muhlemann K. 2009. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis. 9:312-323.
14. Martinez JL. 2012. The antibiotic resistome: challenge and opportunity for therapeutic intervention. Future Med. Chem. 4:347-359.
15. Martinez JL, et al. 2009. A global view of antibiotic resistance. FEMS Microbiol. Rev. 33:44-65.
16. Martinez JL, Rojo F. 2011. Metabolic regulation of antibiotic resistance. FEMS Microbiol. Rev. 35:768-789.
17. Negri MC, Lipsitch M, Blazquez J, Levin BR, Baquero F. 2000. Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrob. Agents Chemother. 44:2485-2491.
18. Ribera A, et al. 2002. Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates. Microb. Drug Resist. 8:245-251.
19. Sanchez MB, Hernandez A, Martinez JL. 2009. Stenotrophomonas maltophilia drug resistance. Future Microbiol. 4:655-660.
20. Sanchez MB, Hernandez A, Rodriguez-Martinez JM, Martinez-Martinez L, Martinez JL. 2008. Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol. 8:148.
21. Sanchez MB, Martinez JL. 2010. SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 54:580-581.
22. Sanchez P, Alonso A, Martinez JL. 2004. Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains expressing different amounts of the multidrug efflux pump SmeDEF. Antimicrob. Agents Chemother. 48:2274-2276.
23. Valdezate S, Vindel A, Saez-Nieto JA, Baquero F, Canton R. 2005. Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains. J. Antimicrob. Chemother. 56:220-223.